Methods of inhibiting uterine fibrosis

US5457116A · kind A · utility

Assignee

• ELI LILLY AND COMPANY · US

Inventors

• Larry J. Black · Indianapolis, US
• George J. Cullinan · Trafalgar, US
• Michael W. Draper · Carmel, US
• Charles D. Jones · Indianapolis, US
• David E. Seyler · Greenfield, US

Key dates

• Filing date: Oct 15, 1993
• Grant date: Oct 10, 1995
• Expiry date: Oct 15, 2013

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P15/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of inhibiting uterine fibrosis comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R.sup.1 and R.sup.3 are independently hydrogen, ##STR2## wherein Ar is optionally substituted phenyl; wherein R.sup.2 is selected from the group consisting of pyrrolidino and piperidino, a pharmaceutically acceptable salt or solvate thereof.